JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$5.47B |
| 2 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$3.17B |
| 3 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$2.05B |
| 4 |
Amazon
AMZN
|
+$1.96B |
| 5 |
Meta Platforms (Facebook)
META
|
+$1.6B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$1.72B |
| 2 |
Vanguard Intermediate-Term Treasury ETF
VGIT
|
+$1.31B |
| 3 |
UnitedHealth
UNH
|
+$1.26B |
| 4 |
Automatic Data Processing
ADP
|
+$1.17B |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$1.08B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 27.28% |
| 2 | Technology | 17.17% |
| 3 | Healthcare | 10.79% |
| 4 | Financials | 9.36% |
| 5 | Consumer Discretionary | 8.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
WW
4026
DELISTED
WW International
WW
| $774K | ﹤0.01% |
187,759
-50,554
| -21% | -$221K |
2016 Q2
27 quarters
|
|
|
PARAP
4027
DELISTED
Paramount Global 5.75% Series A Mandatory Convertible Preferred Stock
PARAP
| $774K | ﹤0.01% |
25,847
-9,326
| -27% | -$285K |
2021 Q4
5 quarters
|
|
4028
Sportradar
SRAD
$3.51B
| $772K | ﹤0.01% |
66,351
-4,922
| -7% | -$57.2K |
2022 Q1
4 quarters
|
|
4029
CALL
Vir Biotechnology
VIR
$1.94B
| $768K | ﹤0.01% |
+33,000
| New | +$844K |
2023 Q1
0 quarters
|
|
|
KLNE
4030
DELISTED
Direxion Daily Global Clean Energy Bull 2X Shares
KLNE
| $768K | ﹤0.01% |
50,000
| – | – |
2021 Q3
6 quarters
|
|
4031
iShares Core Dividend ETF
DIVB
$2B
| $765K | ﹤0.01% |
20,493
-439
| -2% | -$16.7K |
2022 Q4
1 quarter
|
|
4032
Gorman-Rupp
GRC
$1.96B
| $765K | ﹤0.01% |
30,586
+3,072
| +11% | +$81.8K |
2015 Q4
29 quarters
|
|
4033
PUT
Rivian
RIVN
$20.6B
| $765K | ﹤0.01% |
49,400
+41,100
| +495% | +$694K |
2021 Q4
5 quarters
|
|
4034
Intrepid Potash
IPI
$443M
| $763K | ﹤0.01% |
27,667
+4,685
| +20% | +$143K |
2017 Q4
21 quarters
|
|
4035
State Street SPDR S&P 400 Mid Cap Growth ETF
MDYG
$2.84B
| $760K | ﹤0.01% |
11,115
-6,362
| -36% | -$434K |
2016 Q1
28 quarters
|
|
4036
Kinetik
KNTK
$4.33B
| $760K | ﹤0.01% |
24,284
+4,926
| +25% | +$151K |
2019 Q1
16 quarters
|
|
4037
Beam Global
BEEM
$24.4M
| $757K | ﹤0.01% |
47,566
+47,563
| +1,585,433% | +$786K |
2021 Q2
7 quarters
|
|
|
SEPA
4038
DELISTED
SEP Acquisition Corp Class A Common Stock
SEPA
| $756K | ﹤0.01% |
74,884
-116
| -0.2% | -$1.17K |
2022 Q4
1 quarter
|
|
4039
Freedom Holding
FRHC
$11.1B
| $754K | ﹤0.01% |
10,496
+1,212
| +13% | +$82K |
2020 Q2
11 quarters
|
|
|
LPSN
4040
DELISTED
LivePerson
LPSN
| $754K | ﹤0.01% |
11,395
-1,567
| -12% | -$251K |
2016 Q3
26 quarters
|
|
|
DM
4041
DELISTED
Desktop Metal, Inc.
DM
| $754K | ﹤0.01% |
32,767
+6,736
| +26% | +$127K |
2020 Q3
10 quarters
|
|
|
INBX
4042
DELISTED
Inhibrx, Inc. Common Stock
INBX
| $754K | ﹤0.01% |
39,978
+7,707
| +24% | +$179K |
2020 Q4
9 quarters
|
|
4043
PUT
General Dynamics
GD
$88.7B
| $753K | ﹤0.01% |
3,300
-21,300
| -87% | -$4.92M |
2022 Q2
3 quarters
|
|
4044
CALL
AMC Entertainment Holdings
AMC
$2.58B
| $752K | ﹤0.01% |
+15,000
| New | +$794K |
2023 Q1
0 quarters
|
|
4045
iShares MSCI Global Metals & Mining Producers ETF
PICK
$2.4B
| $751K | ﹤0.01% |
17,573
-2,677
| -13% | -$117K |
2022 Q2
3 quarters
|
|
|
KBAL
4046
DELISTED
Kimball International
KBAL
| $750K | ﹤0.01% |
60,420
+17,092
| +39% | +$147K |
2013 Q2
39 quarters
|
|
4047
iShares Core 80/20 Aggressive Allocation ETF
AOA
$3.34B
| $749K | ﹤0.01% |
11,774
+8,463
| +256% | +$529K |
2020 Q4
9 quarters
|
|
|
IAS
4048
DELISTED
Integral Ad Science
IAS
| $748K | ﹤0.01% |
52,375
-4,694
| -8% | -$52.7K |
2021 Q2
7 quarters
|
|
4049
CS Disco
LAW
$279M
| $745K | ﹤0.01% |
112,232
+30,182
| +37% | +$215K |
2021 Q3
6 quarters
|
|
4050
Karyopharm Therapeutics
KPTI
$14.7M
| $742K | ﹤0.01% |
12,711
-86,100
| -87% | -$4.25M |
2013 Q4
37 quarters
|
|
Similar funds
JP Morgan Chase's Q1 2023 Portfolio in Review
As of Q1 2023, JP Morgan Chase held 7,579 positions worth $821B, up 8.2% from $759B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
JP Morgan Chase's Q1 2023 filing shows 751 new, 3,314 increased, 2,056 reduced and 652 closed positions. Its largest new stake was Near Intelligence, Inc. Common Stock: 5,852,099 shares worth $14.7M. The largest sale was Eli Lilly, an estimated $1.72B.
By sector, the portfolio is most concentrated in Miscellaneous at 27% of assets, up from 27% a quarter earlier, followed by Technology and Healthcare.
- JP Morgan Chase's largest Q1 2023 buy was Near Intelligence, Inc. Common Stock: 5,852,099 shares worth $14.7M.
- JP Morgan Chase added most to JPMorgan BetaBuilders Europe ETF in Q1 2023, an estimated $5.47B increase.
- JP Morgan Chase's biggest Q1 2023 reduction was Eli Lilly, cutting an estimated $1.72B.
- JP Morgan Chase fully exited IAA, Inc. Common Stock in Q1 2023, selling an estimated $155M.
- JP Morgan Chase's ten largest holdings make up 17% of its $821B portfolio in Q1 2023.
- JP Morgan Chase opened 751 new positions and closed 652 in Q1 2023.
- JP Morgan Chase's portfolio value rose 8.2% quarter-over-quarter to $821B.
Based on JP Morgan Chase's 13F filing for Q1 2023, filed 11 May 2023.